This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...